BGN Technologies, the technology transfer company for Ben-Gurion University of the Negev (BGU), has signed a licensing agreement for its V-Smart drug delivery technology with Lauren Sciences LLC, a privately held biotechnology company in New York. Lauren Sciences will develop the technology as a platform for treating a variety of diseases that affect the central nervous system, including Parkinson’s, Alzheimer’s and Amyotrophic Lateral Sclerosis (ALS). The V-Smart technology pinpoints where the drug will be released in the brain, to increase efficacy and reduce adverse effects.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts

EU Awards $5M To Greenhouse Solar Panel Project
February 07, 2023

Israel Builds Super-Advanced Children’s Hospital
February 07, 2023

Two Thirds Of Hi-Tech Workers In Israel Are Men, Study Finds
February 06, 2023

Ancient Crop Is Gene-Edited For Modern Farms
February 06, 2023
Facebook comments